Abstract
Diabetes management is complex and requires significant effort from the person with diabetes to achieve recommended self-management behaviours. Achieving guideline concordant self-management is made easier when the person with diabetes is committed to the behaviours. Ambivalence is the psychological state in which a person experiences inconsistent drives; both toward and away from the recommended behaviour. Ambivalence about achieving recommended control over blood glucose is expected in situations of hypoglycaemia, due to the associated dangers. In this paper we demonstrate that hypoglycaemia is a fear event and is likely to elicit strong drives to avoid future hypoglycaemia as a fear coping strategy. For many, this results in hyperglycaemia. If hyperglycaemia to avoid hypoglycaemia is a fear management strategy, then hypoglycaemia management should involve fear management. Few diabetes healthcare providers are trained, skilled and confident in fear management. The purpose of this paper is to review the evidence on the psychological consequences of hypoglycaemia and to outline fear management strategies that can be implemented by diabetes care providers. A step-by-step guide is provided to facilitate understanding of the process of the intervention.
Keywords: Ambivalence, cognitive behavior therapy, fear management, fear of hypoglycemia, graduated behavioural exposure, self-management.
Current Diabetes Reviews
Title:Managing Hypoglycemia in Diabetes May Be More Fear Management Than Glucose Management: A Practical Guide for Diabetes Care Providers
Volume: 10 Issue: 6
Author(s): Michael Vallis, Allan Jones and Frans Pouwer
Affiliation:
Keywords: Ambivalence, cognitive behavior therapy, fear management, fear of hypoglycemia, graduated behavioural exposure, self-management.
Abstract: Diabetes management is complex and requires significant effort from the person with diabetes to achieve recommended self-management behaviours. Achieving guideline concordant self-management is made easier when the person with diabetes is committed to the behaviours. Ambivalence is the psychological state in which a person experiences inconsistent drives; both toward and away from the recommended behaviour. Ambivalence about achieving recommended control over blood glucose is expected in situations of hypoglycaemia, due to the associated dangers. In this paper we demonstrate that hypoglycaemia is a fear event and is likely to elicit strong drives to avoid future hypoglycaemia as a fear coping strategy. For many, this results in hyperglycaemia. If hyperglycaemia to avoid hypoglycaemia is a fear management strategy, then hypoglycaemia management should involve fear management. Few diabetes healthcare providers are trained, skilled and confident in fear management. The purpose of this paper is to review the evidence on the psychological consequences of hypoglycaemia and to outline fear management strategies that can be implemented by diabetes care providers. A step-by-step guide is provided to facilitate understanding of the process of the intervention.
Export Options
About this article
Cite this article as:
Vallis Michael, Jones Allan and Pouwer Frans, Managing Hypoglycemia in Diabetes May Be More Fear Management Than Glucose Management: A Practical Guide for Diabetes Care Providers, Current Diabetes Reviews 2014; 10 (6) . https://dx.doi.org/10.2174/1573399810666141113115026
DOI https://dx.doi.org/10.2174/1573399810666141113115026 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
Call for Papers in Thematic Issues
Advancing Diabetic Wound Healing: Mechanisms and Interventions
In recent years, diabetic wounds have become a global health concern with an increase in the incidence of diabetes. Diabetic wounds are a kind of chronic and refractory ulcer. It is generally due to microcirculatory disturbances and reduced levels of endogenous growth factors. Delayed cutaneous wound healing is a chronic ...read more
Advancing Insights into Type 1 Diabetes: From Mechanisms to Management
Type 1 diabetes (T1D) represents a significant global health challenge, requiring a deep understanding of its complex pathophysiology and the development of innovative strategies for prevention, treatment, and management. This thematic issue highlights the latest progress in understanding the autoimmune processes underlying T1D, advances in beta-cell biology, and novel therapeutic ...read more
Exerscience: management of diabetes by physical activity/exercise
Physical activity/exercise is key to the management of diabetes and its complications. Studies have suggested that increased physical activity or regular exercise is associated with reduced risks of diabetes and its complications. However, challenges remained on how to promote physical activity or exercise efficiently, e.g., increase the adherence to physical ...read more
Next-Generation Drug Delivery Systems for Diabetes: Nanoparticles, Hydrogels, and Phytosome Technologies
This thematic issue, titled "Next-Generation Drug Delivery Systems for Diabetes: Nanoparticles, Hydrogels, and Phytosome Technologies," will focus on advanced formulation science to enhance diabetes treatment. It covers innovative platforms such as nanoparticles, responsive hydrogels, and phytosome technologies for improving the bioavailability, stability, and precision in delivering antidiabetic agents. Key areas ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clozapine Safety, 40 Years Later
Current Drug Safety Side Effects of Atypical Antipsychotic Drugs
Current Pharmaceutical Design Are Antipsychotics Useful in the Treatment of Anorexia Nervosa? A Review of the Literature
Current Psychopharmacology The TRIGR Trial: Testing the Potential Link between Weaning Diet and Type 1 Diabetes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Intracerebral Hemorrhage and Diabetes Mellitus: Blood-Brain Barrier Disruption, Pathophysiology and Cognitive Impairments
CNS & Neurological Disorders - Drug Targets A Critical and Comprehensive Insight on Heme Oxygenase and Related Products Including Carbon Monoxide, Bilirubin, Biliverdin and Ferritin in Type-1 and Type-2 Diabetes
Current Pharmaceutical Design Opportunities for Nano-Formulations in Type 2 Diabetes Mellitus Treatments
Current Pharmaceutical Biotechnology Recommendations for Severe Hypertriglyceridemia Treatment, are there New Strategies?
Current Vascular Pharmacology Evaluation of Early Administration of Insulin Glargine in the Acute Management of Diabetic Ketoacidosis
Current Diabetes Reviews Perioperative Glycemic Management in Insulin Pump Patients Undergoing Noncardiac Surgery
Current Pharmaceutical Design Death by Insulin: Management of Self-Harm and Suicide in Diabetes Management
Current Diabetes Reviews COVID-19 in People with Diabetes: Perspectives from Saudi Arabia
Current Diabetes Reviews Development of Pyrazole Compounds as Antidiabetic Agent: A Review
Letters in Drug Design & Discovery Drug Development Strategy for Type 2 Diabetes: Targeting Positive Energy Balances
Current Drug Targets Fetal Encephalomalacia Secondary to Acute Maternal Blood Loss: A Case Study
New Emirates Medical Journal Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition
Current Vascular Pharmacology Current Concepts in Gastric Motility in Diabetes Mellitus
Current Diabetes Reviews Anti-HCV Prevalence among Diabetic and Non-Diabetic Egyptian Children
Current Diabetes Reviews Effects of β-glucan from Aureobasidium pullulans in a Streptozotocininduced Rat Diabetes Model
Current Nutrition & Food Science Black Fungus: An Alarming Infection During Novel Coronavirus: A Review
Anti-Infective Agents